Jeffrey Eisele

Insider Reports History

Entity
Individual
Location
Apellis Pharmaceuticals, Inc., 100 5 Th Avenue, 3 Rd Floor, Waltham, MA
Signature
/s/ David Watson, attorney-in-fact for Jeffrey Eisele
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey Eisele:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Chief Development Officer Common Stock 57.2K $3.75M $65.53 Jan 30, 2024 Direct
Apellis Pharmaceuticals, Inc. Chief Development Officer Stock Option (Right to Buy) 28.4K $1.88M $66.30 Jan 16, 2024 Direct

Insider Reports Filed by Jeffrey Eisele

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLS Apellis Pharmaceuticals, Inc. Jan 29, 2024 2 -$81.5K 4 Jan 31, 2024 Chief Development Officer
APLS Apellis Pharmaceuticals, Inc. Jan 23, 2024 1 -$470K 4 Jan 24, 2024 Chief Development Officer
APLS Apellis Pharmaceuticals, Inc. Jan 22, 2024 1 -$104K 4 Jan 23, 2024 Chief Development Officer
APLS Apellis Pharmaceuticals, Inc. Jan 17, 2024 1 -$341K 4 Jan 18, 2024 Chief Development Officer
APLS Apellis Pharmaceuticals, Inc. Jan 16, 2024 3 $1.85M 4 Jan 17, 2024 Chief Development Officer
APLS Apellis Pharmaceuticals, Inc. Dec 26, 2023 2 -$18.1K 4 Dec 28, 2023 Chief Development Officer
APLS Apellis Pharmaceuticals, Inc. Feb 23, 2023 1 -$113K 4 Feb 27, 2023 Chief Development Officer
APLS Apellis Pharmaceuticals, Inc. Feb 21, 2023 3 -$48.3K 4 Feb 22, 2023 Chief Development Officer
APLS Apellis Pharmaceuticals, Inc. Jan 30, 2023 1 -$46.6K 4 Jan 31, 2023 Chief Development Officer
APLS Apellis Pharmaceuticals, Inc. Jan 27, 2023 1 -$19.4K 4 Jan 30, 2023 Chief Development Officer
APLS Apellis Pharmaceuticals, Inc. Jan 23, 2023 1 -$231K 4 Jan 25, 2023 Chief Development Officer
APLS Apellis Pharmaceuticals, Inc. Jan 20, 2023 1 -$106K 4 Jan 24, 2023 Chief Development Officer
APLS Apellis Pharmaceuticals, Inc. Jan 12, 2023 2 $1.87M 4 Jan 17, 2023 Chief Development Officer
APLS Apellis Pharmaceuticals, Inc. Apr 25, 2022 2 -$4.6K 4 Dec 23, 2022 Exec VP, Program Team Lead
APLS Apellis Pharmaceuticals, Inc. Jan 28, 2022 1 -$16.7K 4 Feb 1, 2022 Exec VP, Program Team Lead
APLS Apellis Pharmaceuticals, Inc. Jan 21, 2022 2 $0 4 Jan 25, 2022 Exec VP, Program Team Lead
APLS Apellis Pharmaceuticals, Inc. Dec 22, 2021 1 -$4.26K 4 Dec 23, 2021 Exec VP, Program Team Lead